Market Place
Sourcing Support
Aegis Life And Entos Complete Phase 1 Enrollment For Covid Vaccine
19 Sep 2024 //
BUSINESSWIRE
Entos Pharma Doses First Participant In COVID-19 Booster Trial
06 Aug 2024 //
BUSINESSWIRE
Entos Pharmaceuticals Receives Approval From Health Canada To Begin Clinical
10 Jun 2024 //
BUSINESSWIRE
Aegis Life Investment to DevP of DNA-Encoded Therapeutic Antibodies
19 Mar 2024 //
BUSINESSWIRE
Entos Launches GMP Clinical Manufacturing Facility in Carlsbad, California
25 Jan 2024 //
BUSINESSWIRE
Entos Passes Enrollment Milestone in PII Trial of its COVID-19 DNA Vaccine
29 Sep 2022 //
BUSINESSWIRE
Entos Pharmaceuticals Expands R&D Operations into the US
07 Jun 2022 //
BUSINESSWIRE
Entos Pharma Announces Senior Leadership Appointments to Expand Executive Team
03 Mar 2022 //
BUSINESSWIRE
Eli Lilly taps Entos` delivery tech in $50M-plus nucleic acid pact
07 Jan 2022 //
PRESS RELEASE
Lilly, Entos Collaborate for Innovative Therapies in Neurologic Indications
06 Jan 2022 //
PRNEWSWIRE
Entos and BioMarin Enter into Agreement for Product Candidates
15 Nov 2021 //
PRNEWSWIRE
Entos Pharma` COVID-19 DNA Vaccine Candidate Approved for Clinical Trial in SA
01 Sep 2021 //
PIPELINEREVIEW
Entos Raises $53 Million Series A Round Led by Coatue and Catalio
14 Jul 2021 //
BUSINESS WIRE
Entos Raises $53 Million Series A Round Led by Coatue and Catalio
14 Jul 2021 //
BUSINESS WIRE
Aegis Life Announces Start of Phase 1/2 Trial of the Entos COVID-19 DNA Vaccine
16 Apr 2021 //
BUSINESSWIRE
Entos Awarded funding to Conduct Ph I Trial of COVID-19 DNA Vaccine
23 Oct 2020 //
PRNEWSWIRE
Entos Awarded funding to Conduct Phase I Clinical Trial of COVID-19 DNA
23 Oct 2020 //
PRNEWSWIRE
Entos Announces Selection of Lead DNA Vaccine Candidates for COVID-19
25 Jun 2020 //
BUSINESSWIRE
Epivax and Entos Pharmaceuticals to develop DNA-based vaccine for COVID-19
29 Apr 2020 //
NEWS MEDICAL
Entos Is Developing a DNA Vaccine Against COVID-19 Using Its Fusogenix
18 Mar 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.